Immunosuppressive therapies for lupus nephritis (LN) have improved significantly over the
past few decades, resulting in growing number of choices for treatment individualization and …

Systemic lupus erythematosus (SLE) is a chronic multifactorial autoimmune disease that
affects many organs, including the kidney. Lupus nephritis (LN) is a common manifestation …

Lupus nephritis is a severe organ manifestation of systemic lupus erythematosus, and its
pathogenesis involves complex etiology and mechanisms. Despite significant knowledge …

Lupus nephritis is a potentially devastating complication of systemic lupus erythematosus.
Immune cells, cytokines, and epigenetic factors have all been recently implicated in lupus …

Background/Aims: Lupus nephritis is an organ manifestation of systemic autoimmunity.
Current treatment algorithms are still based on unselective immunosuppressive drugs …

Abstract Purpose of Review Update on the diagnosis, treatment, and monitoring of lupus
nephritis. Recent Findings The recent criteria enable the earlier classification of lupus …

Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE) and is
one of the leading causes of morbidity and mortality in patients with SLE. It is estimated that …

Lupus nephritis (LN) is an inflammatory condition of the kidneys that encompasses various
patterns of renal disease including glomerular and tubulointerstitial pathology. It is a major …

Although there has been remarkable progress in our understanding of the immunology and
phenotype of lupus nephritis current therapies have insufficient efficacy. As new therapies …

The collaborative efforts of patients, clinical and translational researchers, the
pharmaceutical industry and funding sources are needed to advance therapies for lupus …